Marché mondial du traitement de la maladie de Batten – Tendances et prévisions de l’industrie jusqu’en 2030

Analyse et taille du marché du traitement de la maladie de Batten

L'augmentation des troubles neurologiques est un facteur majeur de croissance du marché. En outre, l'augmentation des investissements des industries biotechnologiques et pharmaceutiques dans la recherche et le développement devrait encore propulser la croissance du marché du traitement de la maladie de Batten. En outre, la demande croissante de meilleures méthodes de traitement devrait encore amortir la croissance du marché du traitement de la maladie de Batten.

Data Bridge Market Research analyse que le marché du traitement de la maladie de Batten, qui était de 41,39 millions USD en 2022, devrait grimper à 57,89 millions USD d'ici 2030 et devrait connaître un TCAC de 5,4 % au cours de la période de prévision. Le « NCL congénital » domine le segment de type du marché du traitement de la maladie de Batten en raison de la forte prévalence de ce type de maladie. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également des analyses approfondies d'experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché du traitement de la maladie de Batten

Market Definition

Batten disease is a rare, inherent, and fatal nervous system disorder. It is the most general form of a group of disorders named the neuronal ceroid lipofuscinoses (NCLs), which is known to be a class of life-limiting neurogenerative genetic diseases that are triggered because of abnormality of genes resulting in their inability to synthesize the essential protein.

Batten Disease Treatment Market Dynamics

Drivers

• Rising incidences of neurological diseases

The growing prevalence of neurological diseases is among the essential factors intensifying the growth and demand for the batten disease treatment market. This, in turn, has carved the way for market development.

• Research and development proficiencies

Rising expenditure for research and development proficiencies, especially in developed and developing economies, about medical drugs and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted to develop medical drugs also bolstered the market growth rate.

• Growing investment in healthcare facilities

Surging focus on improving the condition of healthcare facilities and improving the overall healthcare infrastructure is another important factor fostering market growth. The rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology further creates lucrative market opportunities.  

Opportunities

• Upsurge in the public-private funding

Furthermore, an upsurge in the public-private funding for target research activities, rising prevalence of neurogenerative diseases, and rising product innovations and development owing to technological advancements worldwide will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. Likewise, the rise in worldwide healthcare expenses will further provide potential opportunities for the growth of the batten disease treatment market in the coming years.

Restraints/Challenges

• Rise in the price of treatment

On the other hand, rise in the price of treatment, high cost associated with research and development proficiencies, and limited infrastructural facilities, at present, only one drug is accepted for batten disease, which is further projected to impede the growth of the batten disease treatment market in the timeline period and dearth of awareness in the backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in developing economies and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.

The global batten disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Batten disease treatment Market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In August 2020, Abeona Therapeutics announced initiating a Phase 1/2 clinical trial of ABO-202, a gene therapy for CLN1 disease.

• In July 2020, Regenxbio announced initiating a Phase 1/2 clinical trial of RGX-181, a gene therapy for CLN2 disease.

Global Batten Disease Treatment Market Scope

The global batten disease treatment market is segmented on the basis of types, drugs, therapy, treatment, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

 Types

• Congenital NCL
• Infantile NCL
• Late Infantile NCL
• Adult NCL

Drug

• Cerliponase Alfa
• Valproic Scid
• Levetiracetam

Therapy

• Occupational Therapy
• Physical Therapy

Treatment

• Medication
• Supportive Care

Route of Administration

• Oral
• Parenteral

End Users

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

Batten Disease Treatment Market Regional Analysis/Insights

The Batten disease treatment Market is analyzed, and market size insights and trends are provided by country, type, drug, therapy, treatment, route of administration, end users, and distribution channel as referenced above.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

North America dominates the Batten Disease Treatment Market because of the strong base of healthcare facilities, the presence of major players in the market, increases cases of neurological diseases among the population, and the rising number of research activities in this region.   

Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increase in government initiatives to promote awareness, rise in healthcare facilities, growing research activities in the region, availability of massive untapped markets, large population pool, and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The Batten Disease Treatment Market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Batten disease treatment Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Batten disease treatment Market. The data is available for historic period 2010-2020.

Competitive Landscape and Batten Disease Treatment Market Share Analysis

The Batten disease treatment Market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to Batten disease treatment Market.

Some of the major players operating in the Batten Disease Treatment Market are:

• Novartis AG (Switzerland)
• Abeona Therapeutics Inc. (États-Unis)
• Alexion Pharmaceuticals Inc. (États-Unis)
• Amicus Therapeutics (États-Unis)
• Lysogène (France)
• Biogen (États-Unis)
• BioMarin Pharmaceutical Inc. (États-Unis)
• Denali Therapeutics (États-Unis)
• Dimension Therapeutics, Inc. (États-Unis)
• Edison Pharmaceuticals (États-Unis)
• GeneTx Biotherapeutics LLC (États-Unis)
• Orchard Therapeutics (Royaume-Uni)
• Passage Bio (États-Unis)
• Teva Pharmaceuticals Industries Ltd. (Irlande)
• Zydus Cadila (Inde)
• Mylan (États-Unis)
• Regenxbio Inc. (États-Unis)

SKU-46723